AG˹ٷ

STOCK TITAN

[Form 4/A] Clover Health Investments, Corp Amended Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4/A
Rhea-AI Filing Summary

Form 4 � Kinder Morgan, Inc. (KMI) discloses that Vice President & General Counsel Catherine C. James settled 51,994 restricted stock units (RSUs) into Class P common shares on 31 Jul 2025 (code M). To satisfy tax-withholding requirements, the issuer retained 19,951 shares at the $28.06 closing price (code F), leaving a net 32,043-share increase in the insider’s direct ownership at zero cash cost.

Post-transaction, James directly owns 142,604 shares and indirectly holds 361 shares (75 via spouse, 286 via 401(k)). All reported RSUs are now fully vested; no derivative securities remain outstanding.

The filing reflects routine equity-compensation settlement rather than discretionary buying or selling, carrying neutral market implications but signalling continued executive equity alignment.

Modulo 4 � Kinder Morgan, Inc. (KMI) comunica che la Vicepresidente e Consigliere Generale Catherine C. James ha convertito 51.994 unità azionarie vincolate (RSU) in azioni ordinarie di Classe P il 31 luglio 2025 (codice M). Per adempiere agli obblighi fiscali, l'emittente ha trattenuto 19.951 azioni al prezzo di chiusura di $28,06 (codice F), lasciando un incremento netto di 32.043 azioni nella proprietà diretta dell'insider senza alcun costo in contanti.

Dopo la transazione, James possiede direttamente 142.604 azioni e detiene indirettamente 361 azioni (75 tramite il coniuge, 286 tramite il piano 401(k)). Tutte le RSU segnalate sono ora completamente maturate; non ci sono titoli derivati in circolazione.

Il deposito riflette una normale liquidazione di compensi azionari piuttosto che un acquisto o vendita discrezionale, con implicazioni di mercato neutrali, ma segnala un continuo allineamento azionario dei dirigenti.

Formulario 4 � Kinder Morgan, Inc. (KMI) revela que la Vicepresidenta y Asesora General Catherine C. James ܾó 51,994 unidades restringidas de acciones (RSUs) en acciones comunes Clase P el 31 de julio de 2025 (código M). Para cumplir con las retenciones fiscales, el emisor retuvo 19,951 acciones al precio de cierre de $28.06 (código F), dejando un incremento neto de 32,043 acciones en la propiedad directa del insider sin costo en efectivo.

Tras la transacción, James posee directamente 142,604 acciones y mantiene indirectamente 361 acciones (75 a través del cónyuge, 286 mediante 401(k)). Todas las RSUs reportadas están completamente adquiridas; no quedan valores derivados pendientes.

El informe refleja una liquidación rutinaria de compensación en acciones más que una compra o venta discrecional, con implicaciones neutrales para el mercado, pero señalando una continua alineación accionaria ejecutiva.

서식 4 � Kinder Morgan, Inc. (KMI)� 부사장 � 법률 고문� Catherine C. James가 2025� 7� 31일에 51,994개의 제한 주식 단위(RSU)� 클래� P 보통주로 정산했다� 공시했습니다(코드 M). 세금 원천징수 요건� 충족하기 위해 발행사는 종가 $28.06� 해당하는 19,951주를 보유했으�(코드 F), 이로 인해 내부자의 직접 소유 주식� 순증 32,043�가 되었습니�.

거래 � James� 직접 142,604�� 보유하고 있으�, 배우자를 통해 75�, 401(k)� 통해 286� � 간접적으� 361주를 보유하고 있습니다. 보고� 모든 RSU� 완전� 베스팅되었으�, 파생 증권은 남아 있지 않습니다.

� 공시� 임의� 매매가 아닌 정기적인 주식 보상 정산� 반영하며, 시장� 중립적인 영향� 가지지� 경영진의 주식 보유 지속성� 나타냅니�.

Formulaire 4 � Kinder Morgan, Inc. (KMI) révèle que la Vice-Présidente et Conseillère Juridique Catherine C. James a réglé 51 994 unités d’actions restreintes (RSU) en actions ordinaires de classe P le 31 juillet 2025 (code M). Pour satisfaire aux exigences de retenue d’impôt, l’émetteur a retenu 19 951 actions au prix de clôture de 28,06 $ (code F), ce qui laisse une augmentation nette de 32 043 actions dans la propriété directe de l’initié sans coût en espèces.

Après la transaction, Mme James possède directement 142 604 actions et détient indirectement 361 actions (75 via son conjoint, 286 via un plan 401(k)). Toutes les RSU déclarées sont désormais entièrement acquises ; aucun titre dérivé n’est en circulation.

Le dépôt reflète un règlement de rémunération en actions de routine plutôt qu’un achat ou une vente discrétionnaire, avec des implications neutres pour le marché mais signalant un alignement continu des dirigeants sur le capital.

Formular 4 � Kinder Morgan, Inc. (KMI) gibt bekannt, dass die Vizepräsidentin und General Counsel Catherine C. James am 31. Juli 2025 51.994 Restricted Stock Units (RSUs) in Stammaktien der Klasse P umgewandelt hat (Code M). Zur Erfüllung der Steuerabzugsverpflichtungen behielt der Emittent 19.951 Aktien zum Schlusskurs von $28,06 ein (Code F), was zu einer netto 32.043 Aktien Erhöhung im direkten Besitz der Insiderin ohne Barausgabe führte.

Nach der Transaktion besitzt James direkt 142.604 Aktien und hält indirekt 361 Aktien (75 über den Ehepartner, 286 über den 401(k)). Alle gemeldeten RSUs sind nun vollständig unverfallbar; keine derivativen Wertpapiere sind mehr ausstehend.

Die Meldung spiegelt eine routinemäßige Abwicklung von Aktienvergütungen wider und nicht einen diskretionären Kauf oder Verkauf, mit neutralen Marktauswirkungen, signalisiert jedoch eine fortgesetzte Ausrichtung der Führungskräfte am Eigenkapital.

Positive
  • Direct ownership increases by 32,043 shares, demonstrating continued executive equity alignment without open-market share sales.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting; insider’s stake grows 23% with no open-market trade—neutral signal.

The settlement of 51.9k RSUs and withholding of 19.9k shares is standard tax administration. Because the insider neither bought nor sold shares on the market, the transaction offers little insight into management’s valuation view. Direct ownership rises to 142.6k shares, enhancing alignment, yet the incremental 32k shares represent <1% of daily KMI volume and are immaterial to float. I classify the filing as not impactful for valuation or trading sentiment.

TL;DR: Compensation-driven transfer, governance posture unchanged.

RSU settlements are built into Kinder Morgan’s executive pay structure. The absence of a 10b5-1 plan box and the mechanical nature of the disposition indicate no intent to time the market. Share withholding for taxes avoids cash outlay and prevents open-market selling pressure. From a governance standpoint, continued equity accumulation by the GC supports shareholder-management alignment, but the event does not materially alter control or incentive architecture.

Modulo 4 � Kinder Morgan, Inc. (KMI) comunica che la Vicepresidente e Consigliere Generale Catherine C. James ha convertito 51.994 unità azionarie vincolate (RSU) in azioni ordinarie di Classe P il 31 luglio 2025 (codice M). Per adempiere agli obblighi fiscali, l'emittente ha trattenuto 19.951 azioni al prezzo di chiusura di $28,06 (codice F), lasciando un incremento netto di 32.043 azioni nella proprietà diretta dell'insider senza alcun costo in contanti.

Dopo la transazione, James possiede direttamente 142.604 azioni e detiene indirettamente 361 azioni (75 tramite il coniuge, 286 tramite il piano 401(k)). Tutte le RSU segnalate sono ora completamente maturate; non ci sono titoli derivati in circolazione.

Il deposito riflette una normale liquidazione di compensi azionari piuttosto che un acquisto o vendita discrezionale, con implicazioni di mercato neutrali, ma segnala un continuo allineamento azionario dei dirigenti.

Formulario 4 � Kinder Morgan, Inc. (KMI) revela que la Vicepresidenta y Asesora General Catherine C. James ܾó 51,994 unidades restringidas de acciones (RSUs) en acciones comunes Clase P el 31 de julio de 2025 (código M). Para cumplir con las retenciones fiscales, el emisor retuvo 19,951 acciones al precio de cierre de $28.06 (código F), dejando un incremento neto de 32,043 acciones en la propiedad directa del insider sin costo en efectivo.

Tras la transacción, James posee directamente 142,604 acciones y mantiene indirectamente 361 acciones (75 a través del cónyuge, 286 mediante 401(k)). Todas las RSUs reportadas están completamente adquiridas; no quedan valores derivados pendientes.

El informe refleja una liquidación rutinaria de compensación en acciones más que una compra o venta discrecional, con implicaciones neutrales para el mercado, pero señalando una continua alineación accionaria ejecutiva.

서식 4 � Kinder Morgan, Inc. (KMI)� 부사장 � 법률 고문� Catherine C. James가 2025� 7� 31일에 51,994개의 제한 주식 단위(RSU)� 클래� P 보통주로 정산했다� 공시했습니다(코드 M). 세금 원천징수 요건� 충족하기 위해 발행사는 종가 $28.06� 해당하는 19,951주를 보유했으�(코드 F), 이로 인해 내부자의 직접 소유 주식� 순증 32,043�가 되었습니�.

거래 � James� 직접 142,604�� 보유하고 있으�, 배우자를 통해 75�, 401(k)� 통해 286� � 간접적으� 361주를 보유하고 있습니다. 보고� 모든 RSU� 완전� 베스팅되었으�, 파생 증권은 남아 있지 않습니다.

� 공시� 임의� 매매가 아닌 정기적인 주식 보상 정산� 반영하며, 시장� 중립적인 영향� 가지지� 경영진의 주식 보유 지속성� 나타냅니�.

Formulaire 4 � Kinder Morgan, Inc. (KMI) révèle que la Vice-Présidente et Conseillère Juridique Catherine C. James a réglé 51 994 unités d’actions restreintes (RSU) en actions ordinaires de classe P le 31 juillet 2025 (code M). Pour satisfaire aux exigences de retenue d’impôt, l’émetteur a retenu 19 951 actions au prix de clôture de 28,06 $ (code F), ce qui laisse une augmentation nette de 32 043 actions dans la propriété directe de l’initié sans coût en espèces.

Après la transaction, Mme James possède directement 142 604 actions et détient indirectement 361 actions (75 via son conjoint, 286 via un plan 401(k)). Toutes les RSU déclarées sont désormais entièrement acquises ; aucun titre dérivé n’est en circulation.

Le dépôt reflète un règlement de rémunération en actions de routine plutôt qu’un achat ou une vente discrétionnaire, avec des implications neutres pour le marché mais signalant un alignement continu des dirigeants sur le capital.

Formular 4 � Kinder Morgan, Inc. (KMI) gibt bekannt, dass die Vizepräsidentin und General Counsel Catherine C. James am 31. Juli 2025 51.994 Restricted Stock Units (RSUs) in Stammaktien der Klasse P umgewandelt hat (Code M). Zur Erfüllung der Steuerabzugsverpflichtungen behielt der Emittent 19.951 Aktien zum Schlusskurs von $28,06 ein (Code F), was zu einer netto 32.043 Aktien Erhöhung im direkten Besitz der Insiderin ohne Barausgabe führte.

Nach der Transaktion besitzt James direkt 142.604 Aktien und hält indirekt 361 Aktien (75 über den Ehepartner, 286 über den 401(k)). Alle gemeldeten RSUs sind nun vollständig unverfallbar; keine derivativen Wertpapiere sind mehr ausstehend.

Die Meldung spiegelt eine routinemäßige Abwicklung von Aktienvergütungen wider und nicht einen diskretionären Kauf oder Verkauf, mit neutralen Marktauswirkungen, signalisiert jedoch eine fortgesetzte Ausrichtung der Führungskräfte am Eigenkapital.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Soares Karen

(Last) (First) (Middle)
C/O CLOVER HEALTH INVESTMENTS, CORP.
NOT APPLICABLE

(Street)
WILMINGTON DE 19801

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel & Secretary
3. Date of Earliest Transaction (Month/Day/Year)
09/13/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
09/17/2024
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/13/2024 A 518,000(1) A $0 1,515,032 D
Class A Common Stock 07/31/2025 F 38,086(2) D $2.89 1,476,946(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed to reflect the full number of RSUs that were achieved.
2. Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.
3. Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 31, 2025.
Remarks:
/s/Peter J. Rivas as attorney-in-fact for Karen M. Soares 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Kinder Morgan shares did Catherine C. James acquire on 31 July 2025?

She received 51,994 shares from RSU vesting, of which 32,043 remained after tax withholding.

What price was used for the tax-withholding disposition in the KMI Form 4?

Shares were withheld at the $28.06 closing price on 31 July 2025.

How many Kinder Morgan shares does the insider now directly own?

Post-transaction, James directly owns 142,604 Class P common shares.

Did the Form 4 involve an open-market purchase or sale?

No. The activity was a mechanical RSU settlement; no discretionary market trade occurred.

Are any derivative securities still outstanding for this insider?

No. The filing indicates zero remaining RSUs following the reported vesting.
Clover Health Investments Corp

NASDAQ:CLOV

CLOV Rankings

CLOV Latest News

CLOV Latest SEC Filings

CLOV Stock Data

1.41B
400.32M
3.77%
27.27%
7.11%
Healthcare Plans
Hospital & Medical Service Plans
United States
JERSEY CITY